Cargando…
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
BACKGROUND: Second allogeneic hematopoietic stem cell transplant (HCT) remains as an option for disease relapse after initial HCT. METHODS: We analyzed retrospectively the outcomes of 65 consecutive patients who underwent a second HCT for disease relapse at the University of Chicago. Univariate and...
Autores principales: | Fan, Yun, Artz, Andrew S., van Besien, Koen, Stock, Wendy, Larson, Richard A., Odenike, Olatoyosi, Godley, Lucy A., Kline, Justin, Cunningham, John M., LaBelle, James L., Bishop, Michael R., Liu, Hongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317199/ https://www.ncbi.nlm.nih.gov/pubmed/30622841 http://dx.doi.org/10.1186/s40164-018-0125-6 |
Ejemplares similares
-
A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia
por: Wang, Amy Y., et al.
Publicado: (2018) -
Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation
por: Lin, Richard J., et al.
Publicado: (2013) -
PD-1 blockade induces remissions in relapsed classical Hodgkin lymphoma following allogeneic hematopoietic stem cell transplantation
por: Godfrey, James, et al.
Publicado: (2017) -
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation
por: Godfrey, James, et al.
Publicado: (2022) -
Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission
por: Lee, Je-Hwan, et al.
Publicado: (2010)